The Wolf Administration today issued grower/processor permits to 13 entities for Phase II of the Medical Marijuana Program. One of the permits goes to Calypso of Erie, which will grow and process marijuana on the former Hammermill Paper Co property on Erie’s eastside.
The Erie growing operation Calypso plans will be located in what was formerly known as the south yard at E 10th & Downing Ave.
“As one can imagine, we are ecstatic,” said Samuel P. “Pat” Black, III, President of Calypso. “This is a huge win for the City of Erie and our team, and we are eager to get started.”
Although Calypso’s initial application was denied during Phase I in 2017, the company re-applied in early 2018, was approved and also received the 3rd highest score of all of the applicants – earning 792.75 points out of 1000 total points.
Calypso is anticipated to bring over 60 full-time jobs with an projected annual payroll of over $2 million at full production capacity and will implement a diversity plan to facilitate hiring of employees that are representative of the greater Erie community.
“I chose this site for a reason,” said Black, “and I want the people of this neighborhood and community to have the opportunity to be involved.” Within the exact zip code of the Calypso facility, the unemployment rate is 9.2%, with a rate of over 36% for African American residents and over 26% for Hispanic residents. Comparably, the current unemployment rate in Pennsylvania as of March 2018 was 4.8%.
Positions will range from entry to executive level, with the potential for upward mobility in each area while maintaining an overall commitment to family-sustaining wages and benefit packages. Calypso projects their average employee salary to be well beyond City of Erie’s median household income of $33,000.
The Calypso facility’s footprint of seven acres will be located in Black’s ‘South Yard,’ the 27-acre brownfield parcels between East Lake Road & East 10th Street, formerly part of Hammermill Paper. The facility itself is planned at the corner of Downing & East 10th Street for over 52,000 square feet — 26,700 for or cultivation, 9,300 for processing/production, 3,000 in laboratory space and 11,800 in ancillary, structure and support space. The Calypso site will be secured by the highest-level security measures while maintaining aesthetic appeal to be attractive to adjacent business.
“In Phase I of the program, we built a framework to give patients access to medical marijuana,” Dr. Levine said. “In this next phase, Phase II, we are fully implementing the program to expand access to this medication to every part of the state. This medication is vital to Pennsylvanians suffering from one of the 21 serious medical conditions allowed under the law and we need to ensure they have access to it close to their homes.”
The department has made applicant information, score cards and a table of the Phase II grower/processor permittees available at www.medicalmarijuana.pa.gov.
The 13 permits were issued to:
PennAlt Organics Inc
Pier Cove LLC
PharmaCann Penn Plant LLC
Green Leaf Medicals, LLC
Whole Plants LLC
Parea BioSciences, LLC
Maitri Genetics, LLC
Hanging Gardens LLC
Calypso Enterprises, LLC
The Department anticipated making redacted Phase II grower/processor permittee applications available by November 2018. The Department anticipates making all remaining Phase II redacted grower/processor applications available at a later date.
More than 52,000 patients have registered to participate in the medical marijuana program, and more than 30,000 of those patients have received their identification cards and are able to visit a dispensary to purchase medical marijuana. More than 1,000 physicians have registered for the program and, of those, more than 700 have been approved as practitioners.
The Medical Marijuana Program was signed into law by Governor Tom Wolf on April 17, 2016. Since that time, the department has:
- Completed temporary regulations for growers/processors, dispensaries, physicians, patients, and laboratories, all of which have been published in the Pennsylvania Bulletin;
- Issued Phase I permits to grower/processors and dispensaries;
- Developed the Medical Marijuana Physician Workgroup;
- Convened the Medical Marijuana Advisory Board;
- Approved six training providers for physician continuing-education;
- Approved four laboratories to test this medication before it is delivered to patients;
- Launched registries for patients and caregivers, as well as practitioners;
- Registered more than 52,000 patients for the program;
- Approved 29 dispensaries and 12 grower/processers to begin operations;
- Continued to work with permittees to ensure they will be operational; and
- Issued Phase II permit applications for dispensaries; and
- Issued Phase II permits to grower/processors.
The Medical Marijuana Program offers medical marijuana to patients who are residents of Pennsylvania and under a practitioner’s care for the treatment of a serious medical condition as defined by the Medical Marijuana Law.